sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Incretin-Based Drugs Market Size study, by Drug Class, by Route of Administration, by Distribution Channel and Regional Forecasts 2022-2032

Global Incretin-Based Drugs Market Size study, by Drug Class, by...

Home / Categories / Healthcare
Global Incretin-Based Drugs Market Size study, by Drug Class, by Route of Administration, by Distribution Channel and Regional Forecasts 2022-2032
Global Incretin-Based Drugs Market Size...
Report Code
RO1/103/2845

Publish Date
13/Aug/2024

Pages
200
PRICE
$ 4250/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 4950/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 5650/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Table of Contents
Chapter 1. Global Incretin-Based Drugs Market Executive Summary
1.1. Global Incretin-Based Drugs Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Drug Class
1.3.2. By Route of Administration
1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Incretin-Based Drugs Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Incretin-Based Drugs Market Dynamics
3.1. Market Drivers
3.1.1. Rising Prevalence of Type 2 Diabetes
3.1.2. Surge in R&D of Diabetes Therapies
3.2. Market Challenges
3.2.1. Side Effects Associated with Excessive Use
3.2.2. High Cost of Incretin Drugs High Costs
3.3. Market Opportunities
3.3.1. Increase In Pipeline of Incretin-Based Products
Chapter 4. Global Incretin-Based Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Incretin-Based Drugs Market Size & Forecasts by Drug Class 2022-2032
5.1. Segment Dashboard
5.2. Global Incretin-Based Drugs Market: Drug Class Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. GLP-1 receptor agonists
5.2.2. DPP-4 inhibitors
Chapter 6. Global Incretin-Based Drugs Market Size & Forecasts by Route of Administration 2022-2032
6.1. Segment Dashboard
6.2. Global Incretin-Based Drugs Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Oral
6.2.2. Parenteral
Chapter 7. Global Incretin-Based Drugs Market Size & Forecasts by Distribution Channel 2022-2032
7.1. Segment Dashboard
7.2. Global Incretin-Based Drugs Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospital Pharmacies
7.2.2. Drug Stores and Retail Pharmacies
7.2.3. Online Providers
Chapter 8. Global Incretin-Based Drugs Market Size & Forecasts by Region 2022-2032
8.1. North America Incretin-Based Drugs Market
8.1.1. U.S. Incretin-Based Drugs Market
8.1.1.1. Drug Class breakdown size & forecasts, 2022-2032
8.1.1.2. Route of Administration breakdown size & forecasts, 2022-2032
8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
8.1.2. Canada Incretin-Based Drugs Market
8.2. Europe Incretin-Based Drugs Market
8.2.1. U.K. Incretin-Based Drugs Market
8.2.2. Germany Incretin-Based Drugs Market
8.2.3. France Incretin-Based Drugs Market
8.2.4. Spain Incretin-Based Drugs Market
8.2.5. Italy Incretin-Based Drugs Market
8.2.6. Rest of Europe Incretin-Based Drugs Market
8.3. Asia-Pacific Incretin-Based Drugs Market
8.3.1. China Incretin-Based Drugs Market
8.3.2. India Incretin-Based Drugs Market
8.3.3. Japan Incretin-Based Drugs Market
8.3.4. Australia Incretin-Based Drugs Market
8.3.5. South Korea Incretin-Based Drugs Market
8.3.6. Rest of Asia Pacific Incretin-Based Drugs Market
8.4. Latin America Incretin-Based Drugs Market
8.4.1. Brazil Incretin-Based Drugs Market
8.4.2. Mexico Incretin-Based Drugs Market
8.4.3. Rest of Latin America Incretin-Based Drugs Market
8.5. Middle East & Africa Incretin-Based Drugs Market
8.5.1. Saudi Arabia Incretin-Based Drugs Market
8.5.2. South Africa Incretin-Based Drugs Market
8.5.3. Rest of Middle East & Africa Incretin-Based Drugs Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Sun Pharmaceutical Industries Ltd.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Lupin
9.3.3. Takeda Pharmaceutical Company Ltd.
9.3.4. AstraZeneca plc
9.3.5. Boehringer Ingelheim International GmbH
9.3.6. Eli Lilly and Company
9.3.7. Novartis AG
9.3.8. Novo Nordisk A/S
9.3.9. Merck & Co., Inc
9.3.10. Sanofi
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com